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Popular media initially portrayed
lasers, the brightest light sources in
the known universe, as a ‘‘death ray’’.
Instead, lasers became minimally
destructive, precise, versatile surgical
tools that also enabled a revolution in
biological sciences through live-tissue
microscopy. How did that happen, and
what might come next? It turns out that
laser capabilities—impressive optical
power density, collimation, coherence,
well-defined wavelength, and impress-
ively brief pulses—are better suited
for gentle precision than for wanton
destruction. This trend has been going
strong for 30 years and shows no signs
of slowing down.
The need for a better treatment of
port wine stains (PWS) led us to hatch
the concept of ‘‘selective photothermo-
lysis’’ (SP) (Anderson and Parrish,
1983), which became the basis for
many new therapeutic lasers. Light
passes harmlessly through space and
matter until it is absorbed. It stands to
reason that heating (and other events
caused by light) begins when and
where the light is absorbed. Skin
contains specific structures with a high
concentration of light-absorbing mole-
cules (chromophores), such as the
abnormal blood vessels of PWS.
Intense pulses of light at wavelengths
preferentially absorbed in these ‘‘target’’
structures can cause selective thermal
damage. We showed this for micro-
vessels in skin using yellow light pulses
and for melanin-pigmented cells using
UV light pulses. For the best selectivity,
heat should be confined to the target
during the light pulse. In other words,
pulse duration should be about equal to
the time it takes for cooling the target.
Thermal relaxation time turns out to
vary with the square of target size. For
targets ranging from subcellular particles
(nm scale) to multicellular structures
(mm scale), thermal relaxation time
varies a million-fold, from nanoseconds
to milliseconds.
These simple ideas led to a burst
of new applications for nonscarring,
pulsed lasers over a wide range of pulse
duration and wavelength, including
lasers that did not previously exist.
Millisecond pulsed dye lasers (PDLs)
for treating microvascular malforma-
tions are the first example of any laser
specifically invented for a medical
need, and they remain the treatment
of choice for neonatal and childhood
PWS (Chapas et al., 2007). The latest
generation of PDLs has variable pulse
duration to match various target vessel
sizes, and uses dynamic cryogen spray
cooling for epidermal protection in
pigmented skin. However, PWS treat-
ment remains challenging because a
residual vascular lesion almost always
persists. Three reasons are hypothe-
sized to account for persistence of
PWS—(a) angiogenesis produces new
PWS vessels after each laser treatment,
(b) insufficient depth of PDL treatment,
and (c) an intrinsic lack of sympathetic
innervation. These might be overcome.
The first report of combined PDL
plus the angiogenesis inhibitor drug
rapamycin (Nelson et al., 2011)—and
for adults with hypertrophic PWS,
the use of deeply penetrating near-
infrared wavelengths—is highly effec-
tive (Izikson et al., 2009). PWS
being microvenous lesions, in theory
a source could be made that targets
de-oxyhemoglobin, sparing the arterial
circulation (Rubin et al., 2012). Other
indications for PDLs and their cousin
technologies include rosacea, scars,
ulcerated infantile hemangioma,
warts, and laryngeal lesions including
carcinomas.
The precision with which very
short (nanosecond 109 s, or shorter)
pulses can target individual pigmented
cells or organelles is impressive. In
our initial investigation of SP, we found
that even Langerhans cells adjacent
to pigmented epidermal cells were un-
affected. Ophthalmology subsequently
developed this as a successful treat-
ment for early-stage glaucoma,
targeting pigmented cells in the trabe-
cular meshwork (Latina et al., 1998).
In dermatology, Q-switched red and
near-infrared lasers proved to be excel-
lent for treating some melanocytoses
such as nevus of Ota, useful for cafe´-
au-lait macules and lentigines, but
generally a failure for other conditions
such as Becker’s nevi. As one might
expect, the biology of particular pig-
mented skin lesions critically affects
their response to laser treatment. The
pigmented, well-differentiated dermal
melanocytes of nevus of Ota are easily
removed by Q-switched ruby, alexan-
drite, or Nd:YAG laser treatment
(Taylor et al., 1991). In contrast, con-
genital melanocytic nevi include both
pigmented and nonpigmented melano-
cytes at various levels of differentiation.
Surgical excision is the preferred
treatment, and lasers offer a useful
alternative only in some cases. Other
fascinating aspects of laser targeting of
melanocytes have never been deve-
loped. For example, sublethal fluences
from these Q-switched lasers stimulate
melanogenesis and tanning of the skin.
Tattoos are a poorly regulated form
of ancient nanotechnology. Insoluble,
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indigestible ink particles ranging from
about 50 to 2,000 nm in size are
permanently trapped in phagocytic
dermal cells. Tattoo ‘‘removal’’ uses
Q-switched lasers to selectively rupture
these ink-containing cells. Some of the
liberated ink is shed from the skin
surface, appears in lymph nodes, or
remains in the skin after each treat-
ment. (Taylor et al., 1991) Almost half
of US young adults have a tattoo, and
many of them come to regret it, but
very few seek laser tattoo removal
(Laumann and Derick, 2006). After
nearly a year of monthly Q-switched
laser treatments, about 70% of tattoos
are removed without side effects, and
30% are not. Recent work suggests that
repeated laser exposures given 20 min
apart (Kossida et al., 2012) and the use
of picosecond (1012 s) laser pulses
are more effective (Ross et al., 1998;
Brauer et al., 2012). We are getting
close to being able to remove tattoos in
a day’s work, much as they are created.
If so, would that capability be wisely
used, or would tattoos become even
more common? A modern version of
tattoos is being developed for cancer
therapy. Systemically delivered gold
nanoparticles coated with molecules
that bind to tumors are preferentially
retained, after which laser exposure
can be used to kill the tumor (Von
Maltzahn et al., 2009).
Sometimes the biological target is
not itself pigmented, but there is a
chromophore nearby. An ‘‘extended
theory’’ of SP describes this situation
(Altshuler et al., 2001). Permanent laser
hair reduction is a good example.
Melanin normally exists in the epi-
dermis, hair shafts, and matrix at the
bottom of the hair follicles. Follicular
epithelial stem cells appear to be an
important target for permanent hair
loss. These nonpigmented stem cells
are located in the outer root sheath,
at some distance from the hair shaft
(Lyle et al., 1998). Early attempts at
laser hair removal failed because they
used short, Q-switched laser pulses that
vaporized the pigmented hair shafts,
but did not allow sufficient time for
heat conduction to the outer root
sheath. Therefore, we tested whether
millisecond-domain pulses of red light
could permanently remove pigmented
hair (Dierickx et al., 1998), using a
ruby laser similar to the first-ever laser
built by Ted Maiman in 1960. At
present, permanent hair reduction is
the most popular biomedical use of
lasers. Why did it take more than 30
years to come up with this application,
using the oldest laser in world?
Alexandrite, diode, Nd:YAG lasers,
and IPLs have since replaced ruby
lasers for pigmented hair removal.
Enigmas remain, such as the side
effect of permanently stimulated hair
growth, which occurs on the face in
Mediterranean women.
The concept of thermal confinement
was extended to surgical CO2 lasers,
which can precisely ablate (remove)
tissue, leaving a very thin layer of
residual thermal injury. Richard
Fitzpatrick introduced laser resurfacing
as an alternative to dermabrasion and
deep chemical peels for photoaged
skin (Fitzpatrick et al., 1996). The
entire epidermis and papillary dermis
are removed. Re-epithelialization and
dermal remodeling thereafter leaves a
more youthful appearance, and pro-
foundly decreases the rate of skin
cancer in high-risk patients. Delayed,
permanent hypopigmentation after CO2
laser resurfacing in Caucasians led to
a search for alternatives, although the
procedure remains very useful for
selected patients. Nonablative, mid-
infrared lasers (diode and 1326 nm
Nd:YAG lasers) were developed that
preserve the epidermis while heating
the upper and mid-dermis. Despite mini-
mal efficacy for photoaging, these lasers
entered dermatology to stay, as the first
example of ‘‘fractional’’ laser treatment.
Fractional photothermolysis (Manstein
et al., 2004) is a nonselective cousin
of SP, which uses focused laser micro-
beams to make hundreds to thousands of
small, vertical columns of thermal injury
per cm2 of skin. Each microthermal
damage zone is about the size of a hair
follicle and heals by local remodeling
rather than by scar tissue (Laubach et al.,
2006; Hantash et al., 2007). This fact
poses a basic, unanswered question for
skin biology—what are the criteria and
mechanisms for which a small wound
stimulates tissue remodeling rather than
replacement with scar tissue? In prac-
tice, the laser technology previously
used for skin resurfacing was reborn.
Fractional ablative CO2 and erbium
lasers are now popular, and a non-
ablative fractional laser is even approved
for consumer use at home. Looking
forward, fractional laser treatment will
probably find a number of unexpected
uses. This is the first laser treatment that
accurately controls both anatomic depth
and the percentage (fraction) of skin
treated. Deep channels created by
ablative fractional lasers can deliver
topically applied drugs and macro-
molecules into skin (Haedersdal et al.,
2010). Surprisingly, even dense scars
heal by remodeling after fractional laser
treatment, with the creation of normal
elastic fibers, and in some cases new
hair follicles. Still, the present generation
of fractional lasers is ‘‘dumb’’—unlike
SP, they are not targeted. Potentially,
imaging could be used to make
‘‘smart’’ fractional microbeam lasers,
i.e., treatment devices that offer
software-programmable targeting.
In vivo laser microscopy has already
revolutionized biological research, and
it could eventually change dermato-
pathology. There are several distinct
strategies. Confocal scanning laser
microscopy captures reflected or fluor-
escent light from a thin (B4 mm) plane
inside the tissue, corresponding to a
scanned laser focal spot. Resolution is
equal to conventional light micro-
scopy, revealing cells and extracellular
matrix architecture. Pigmented lesions,
capillary blood flow, inflammatory cell
migration, melanoma, and non-mela-
noma skin cancer margins can be seen,
without harming the tissue (Rajadhyaksha
et al., 1995). However, depth of imaging
is limited to the superficial dermis, and
there are no stains—confocal scanning
laser microscopy is an exercise in micro-
scopic morphology per se. In contrast,
optical coherence tomography is the
optical equivalent of ultrasound, using
an interferometer to detect the depth
from which light is back-scattered
inside the tissue (Huang et al., 1991).
Optical coherence tomography is widely
used in ophthalmology, cardiology, and
(emerging) gastroenterology for high-
speed microscopy of retina, coronary
arteries, and esophagus, respectively.
Recent versions of optical coherence
tomography can produce the deep
E22 JUNE 2013 MILESTONES | CUTANEOUS BIOLOGY
vertical sections familiar to dermato-
pathologists, show 3-D microvascu-
lature of carcinomas in exquisite detail,
and combine cellular resolution, high
speed, depth, and large field of view.
(Vakoc et al., 2009)
The advent of femtosecond (1015 s)
lasers made it possible to achieve very
high power density at a focal spot,
without depositing much energy.
When power density exceeds about
109 W/cm2, more than one photon is
absorbed simultaneously by a chromo-
phore molecule. Multiphoton micro-
scopy stimulates fluorescence in a thin
image plane within live tissue. Multi-
photon laser microscopy is widely used
in the biological sciences, to image
fluorescent probes and optical reporter
genes such as green fluorescent pro-
tein. In skin, the endogenous fluoro-
phores of tryptophan, NADH, and
elastin provide detailed views of
cells, extracellular matrix, and eosino-
phils (Masters et al., 1997). A radically
different form of laser microscopy is
photoacoustic imaging, in which a
laser pulse is used to excite acoustic
waves that are detected at the tissue
surface. Photoacoustic imaging com-
bines the excellent contrast of light,
with the excellent depth of ultrasound
imaging. Pigmented melanoma and
other tumors can be imaged in detail,
up to several centimeter deep into
tissue (Wang and Hu, 2012). There is
an unprecedented opportunity now to
‘‘translate’’ these imaging technologies
into clinical use for dermatopathology
and dermatology.
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